Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP209316.RACsXRtEg9StZ_tmGWR-R1_mfyyiRS5vHWbOHS-bCLlgw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP209316.RACsXRtEg9StZ_tmGWR-R1_mfyyiRS5vHWbOHS-bCLlgw130_assertion type Assertion NP209316.RACsXRtEg9StZ_tmGWR-R1_mfyyiRS5vHWbOHS-bCLlgw130_head.
- NP209316.RACsXRtEg9StZ_tmGWR-R1_mfyyiRS5vHWbOHS-bCLlgw130_assertion description "[Based in part on these data, PKC412 was administered to a patient with t(8;13)(p11;q12) and was efficacious in treatment of progressive myeloproliferative disorder with organomegaly.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP209316.RACsXRtEg9StZ_tmGWR-R1_mfyyiRS5vHWbOHS-bCLlgw130_provenance.
- NP209316.RACsXRtEg9StZ_tmGWR-R1_mfyyiRS5vHWbOHS-bCLlgw130_assertion evidence source_evidence_literature NP209316.RACsXRtEg9StZ_tmGWR-R1_mfyyiRS5vHWbOHS-bCLlgw130_provenance.
- NP209316.RACsXRtEg9StZ_tmGWR-R1_mfyyiRS5vHWbOHS-bCLlgw130_assertion SIO_000772 15448205 NP209316.RACsXRtEg9StZ_tmGWR-R1_mfyyiRS5vHWbOHS-bCLlgw130_provenance.
- NP209316.RACsXRtEg9StZ_tmGWR-R1_mfyyiRS5vHWbOHS-bCLlgw130_assertion wasDerivedFrom befree-20140225 NP209316.RACsXRtEg9StZ_tmGWR-R1_mfyyiRS5vHWbOHS-bCLlgw130_provenance.
- NP209316.RACsXRtEg9StZ_tmGWR-R1_mfyyiRS5vHWbOHS-bCLlgw130_assertion wasGeneratedBy ECO_0000203 NP209316.RACsXRtEg9StZ_tmGWR-R1_mfyyiRS5vHWbOHS-bCLlgw130_provenance.